Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000245282 | SCV000305448 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000726270 | SCV000343332 | uncertain significance | not provided | 2016-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000245282 | SCV000515386 | likely benign | not specified | 2016-02-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001078611 | SCV001008574 | benign | Long QT syndrome | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002347952 | SCV002622682 | likely benign | Cardiovascular phenotype | 2017-12-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000245282 | SCV003929074 | benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing |